Creating a Mouse Model for Studying SARS-CoV-2 Infection
Author Information
Author(s): Matsumoto Yusuke, Honda Tomoko, Yasui Fumihiko, Endo Akinori, Sanada Takahiro, Toyama Sakiko, Takagi Asako, Munakata Tsubasa, Kono Risa, Yamaji Kenzaburo, Yamamoto Naoki, Saeki Yasushi, Kohara Michinori
Primary Institution: Tokyo Metropolitan Institute of Medical Science
Hypothesis
Can an adenoviral vector expressing human ACE2 create a mouse model that mimics COVID-19 pathology?
Conclusion
The study successfully developed a mouse model that exhibits severe pneumonia similar to human COVID-19 after infection with SARS-CoV-2.
Supporting Evidence
- The model showed severe pneumonia with significant weight loss in infected mice.
- Histopathological analysis revealed thickened alveolar walls and inflammatory cell infiltration.
- Viral replication was confirmed through quantitative real-time RT-PCR.
- Elevated levels of inflammatory cytokines were observed in the infected mice.
- Proteomic analysis indicated distinct lung proteomes associated with different SARS-CoV-2 strains.
Takeaway
Researchers made a special mouse that can get sick from the same virus that makes people sick with COVID-19, helping them study the disease better.
Methodology
Mice were inoculated with an adenoviral vector expressing hACE2 and then infected with SARS-CoV-2 to assess disease severity and viral replication.
Potential Biases
Potential bias in the interpretation of results due to the specific mouse strain used.
Limitations
The model may not fully replicate all aspects of human COVID-19 pathology.
Participant Demographics
Specific pathogen-free 7-8-week-old female BALB/c CrSLC mice were used.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website